These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 18452176)

  • 41. Nanocarrier possibilities for functional targeting of bioactive peptides and proteins: state-of-the-art.
    Moutinho CG; Matos CM; Teixeira JA; Balcão VM
    J Drug Target; 2012 Feb; 20(2):114-41. PubMed ID: 22023555
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Two- and three-layer tablet drug delivery systems for oral sustained release of soluble and poorly soluble drugs.
    Efentakis M; Naseef H; Vlachou M
    Drug Dev Ind Pharm; 2010 Aug; 36(8):903-16. PubMed ID: 20196641
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Physicochemical characterization of colloidal drug delivery systems such as reverse micelles, vesicles, liquid crystals and nanoparticles for topical administration.
    Müller-Goymann CC
    Eur J Pharm Biopharm; 2004 Sep; 58(2):343-56. PubMed ID: 15296960
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Microemulsions as transdermal drug delivery vehicles.
    Kogan A; Garti N
    Adv Colloid Interface Sci; 2006 Nov; 123-126():369-85. PubMed ID: 16843424
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Stable drug encapsulation in micelles and microemulsions.
    Narang AS; Delmarre D; Gao D
    Int J Pharm; 2007 Dec; 345(1-2):9-25. PubMed ID: 17945446
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Delivery of ionizable hydrophilic drugs based on pharmaceutical formulation of ion pairs and ionic liquids.
    Gamboa A; Schüßler N; Soto-Bustamante E; Romero-Hasler P; Meinel L; Morales JO
    Eur J Pharm Biopharm; 2020 Nov; 156():203-218. PubMed ID: 32976927
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Formulation of multifunctional oil-in-water nanosized emulsions for active and passive targeting of drugs to otherwise inaccessible internal organs of the human body.
    Tamilvanan S
    Int J Pharm; 2009 Oct; 381(1):62-76. PubMed ID: 19666097
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Colloidal carriers for ophthalmic drug delivery.
    Mainardes RM; Urban MC; Cinto PO; Khalil NM; Chaud MV; Evangelista RC; Gremiao MP
    Curr Drug Targets; 2005 May; 6(3):363-71. PubMed ID: 15857294
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dual influence of colloidal silica on skin deposition of vitamins C and E simultaneously incorporated in topical microemulsions.
    Rozman B; Gosenca M; Gasperlin M; Padois K; Falson F
    Drug Dev Ind Pharm; 2010 Jul; 36(7):852-60. PubMed ID: 20515405
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmaceutical approaches to colon targeted drug delivery systems.
    Chourasia MK; Jain SK
    J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Polyion-induced aggregation of oppositely charged liposomes and charged colloidal particles: the many facets of complex formation in low-density colloidal systems.
    Cametti C
    Chem Phys Lipids; 2008 Oct; 155(2):63-73. PubMed ID: 18718458
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assembling nanoparticle coatings to improve the drug delivery performance of lipid based colloids.
    Simovic S; Barnes TJ; Tan A; Prestidge CA
    Nanoscale; 2012 Feb; 4(4):1220-30. PubMed ID: 22159191
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Colloidal drug delivery system: amplify the ocular delivery.
    Ali J; Fazil M; Qumbar M; Khan N; Ali A
    Drug Deliv; 2016; 23(3):710-26. PubMed ID: 24892625
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Colloidal drug delivery systems in vaccine delivery.
    Beg S; Samad A; Nazish I; Sultana R; Rahman M; Ahmad MZ; Akbar M
    Curr Drug Targets; 2013 Jan; 14(1):123-37. PubMed ID: 23072326
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Poly(methyl methacrylate) particulate carriers in drug delivery.
    Bettencourt A; Almeida AJ
    J Microencapsul; 2012; 29(4):353-67. PubMed ID: 22251239
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Engineered chylomicron mimicking carrier emulsome for lymph targeted oral delivery of methotrexate.
    Paliwal R; Paliwal SR; Mishra N; Mehta A; Vyas SP
    Int J Pharm; 2009 Oct; 380(1-2):181-8. PubMed ID: 19576973
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reverse micelle-loaded lipid nanocarriers: a novel drug delivery system for the sustained release of doxorubicin hydrochloride.
    Vrignaud S; Anton N; Gayet P; Benoit JP; Saulnier P
    Eur J Pharm Biopharm; 2011 Sep; 79(1):197-204. PubMed ID: 21345371
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rational design of new product candidates: the next generation of highly deformable bilayer vesicles for noninvasive, targeted therapy.
    Cevc G
    J Control Release; 2012 Jun; 160(2):135-46. PubMed ID: 22266051
    [TBL] [Abstract][Full Text] [Related]  

  • 59. pH-driven colloidal transformations based on the vasoactive drug nicergoline.
    Salentinig S; Tangso KJ; Hawley A; Boyd BJ
    Langmuir; 2014 Dec; 30(49):14776-81. PubMed ID: 25409414
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Emerging role of colloidal drug delivery systems (CDDS) in NSAID topical administration.
    Puglia C; Tirendi GG; Bonina F
    Curr Med Chem; 2013; 20(14):1847-57. PubMed ID: 23410154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.